Skip to main content
Gastroenterology
Tu1756 TWO SPATIAL TRANSCRIPTOMIC PLATFORMS IDENTIFIED POTENTIAL PATHWAYS LINKED TO VEDOLIZUMAB RESPONSIVENESS IN ULCERATIVE COLITIS.
Our New President-Maria T. Abreu, MD, AGAF.
VEDOLIZUMAB RESPONSE AND NON-RESPONSE IN ULCERATIVE COLITIS: INSIGHTS FROM SPATIAL TRANSCRIPTOMICS.
A comparison of large language model versus manual chart review for extraction of data elements from the electronic health record.
American Indian and Alaska Native Digestive Health: Challenges, Opportunities, and a Path Forward.
How to effectively engage with preclinical medical learners.
Su1049 ADHERENCE TO GUIDELINES FOR SURVEILLANCE AND CHEMOPREVENTION OF NON-DYSPLASTIC BARRETT'S ESOPHAGUS.
730 IMPACT OF SURVEILLANCE AND SOCIAL DETERMINANTS OF HEALTH ON TREATMENT RECEIPT AND HEALTHCARE COSTS IN PATIENTS WITH HCC.
Tu1550 UTILITY OF A BIOMARKER-DERIVED SCORE FOR TREATMENT RESPONSE ASSESSMENT IN PATIENTS WITH HEPATOCELLULAR CARCINOMA.
Sa1609 POLYCYSTIC OVARY SYNDROME INCREASES FIBROSIS SEVERITY IN YOUNG WOMEN WITH NAFLD.
